Skip to main content

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding Akero Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of AKRO: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders2401257+18
Shares86.4M1.61K92.1M+5.71M (+6.6%)
Value$3.50B$65.1K$4.92B+$1.41B (+40.3%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (57)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to AKRO in Q2 2025
InstitutionSharesValue% of portfolio
Avoro Capital Advisors LLC3,500,000$186.8M3.27%
Holocene Advisors, LP1,075,642$57.4M0.14%
Frazier Life Sciences Management, L.P.366,784$19.6M0.78%
Siren, L.L.C.318,647$17.0M0.88%
PFM Health Sciences, LP266,167$14.2M1.23%
First Turn Management, LLC114,554$6.11M1.14%
Nan Fung Trinity (HK) Ltd110,650$5.90M0.71%
Great Point Partners LLC103,848$5.54M3.60%
Balyasny Asset Management LLC96,371$5.14M0.01%
CI Private Wealth, LLC73,553$3.92M0.01%
AXA S.A.70,987$3.79M0.01%
Connor, Clark & Lunn Investment Management Ltd.41,328$2.21M0.01%
Nicholas Investment Partners, LP39,492$2.11M0.19%
Y-Intercept (Hong Kong) Ltd39,002$2.08M0.05%
Weiss Asset Management LP28,526$1.52M0.02%
Twinbeech Capital LP26,022$1.39M0.03%
Brevan Howard Capital Management LP23,426$1.25M0.01%
Acuta Capital Partners, LLC19,772$1.06M1.47%
Graham Capital Management, L.P.18,303$976.6K0.03%
Susquehanna Portfolio Strategies, LLC15,756$840.7K0.02%
Nebula Research & Development LLC14,793$789.4K0.07%
Symmetry Investments LP10,500$560.3K0.05%
Hunting Hill Global Capital, LLC10,301$549.7K0.30%
OP Asset Management Ltd8,761$467.5K0.01%
Public Employees Retirement Association of Colorado8,148$435.0K0.00%
Harvest Management LLC7,500$400.2K0.19%
Engineers Gate Manager LP7,474$398.8K0.00%
DLD Asset Management, LP7,107$379.2K0.04%
Trexquant Investment LP6,383$340.6K0.00%
North Star Asset Management Inc5,700$304.2K0.01%
Legato Capital Management LLC5,322$284.0K0.03%
Palumbo Wealth Management LLC4,910$262.0K0.08%
Mackenzie Financial Corp4,798$256.0K0.00%
JustInvest LLC4,654$248.3K0.00%
RSM US Wealth Management LLC4,246$226.6K0.00%
Neuberger Berman Group LLC4,112$219.4K0.00%
Farallon Capital Management, L.L.C.4,000$213.4K0.00%
Optimize Financial Inc3,920$209.2K0.13%
Janney Montgomery Scott LLC3,810$203.0K0.00%
Global Retirement Partners, LLC1,923$102.6K0.00%
TD Waterhouse Canada Inc.1,380$70.9K0.00%
FNY Investment Advisers, LLC535$28.0K0.01%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.492$26.0K0.00%
Jones Financial Companies LLLP50$2.81K0.00%
Northwestern Mutual Wealth Management Co52$2.77K0.00%
Trust Co of Toledo NA50$2.67K0.00%
UMA Financial Services, Inc.44$2.35K0.00%
J.Safra Asset Management Corp39$2.08K0.00%
MAI Capital Management31$1.66K0.00%
WealthCollab, LLC27$1.44K0.00%
Mid-American Wealth Advisory Group, Inc.18$9600.00%
CIBC Private Wealth Group, LLC13$6940.00%
Rialto Wealth Management, LLC12$6410.00%
Farther Finance Advisors, LLC11$5870.00%
Bare Financial Services, Inc10$5340.00%
Essential Partners LLC5$2670.00%
Twin Peaks Wealth Advisors, LLC4$1920.00%

Sold out (39)

Institutions that held Akero Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of AKRO in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Lord, Abbett & Co. LLC527,004$21.3M
Voloridge Investment Management, LLC501,485$20.3M
Rheos Capital Works Inc.276,000$11.2M
Jane Street Group, LLC182,457$7.39M
Cubist Systematic Strategies, LLC174,960$7.08M
Qube Research & Technologies Ltd150,142$6.08M
ExodusPoint Capital Management, LP103,930$4.21M
Sio Capital Management, LLC85,000$3.44M
Exome Asset Management LLC76,379$3.09M
EAM Investors, LLC66,422$2.69M
Two Sigma Investments, LP62,020$2.51M
Man Group plc45,709$1.85M
Simplex Trading, LLC40,853$1.65M
Dark Forest Capital Management LP38,190$1.55M
Corebridge Financial, Inc.36,523$1.48M
Aigen Investment Management, LP20,253$819.8K
Springhill Fund Asset Management (HK) Co Ltd19,925$806.6K
UBS Oconnor LLC18,800$761.0K
Verition Fund Management LLC18,417$745.5K
Quadrature Capital Ltd18,273$739.7K
FORA Capital, LLC16,473$666.8K
Fox Run Management, L.L.C.15,848$641.5K
Wolverine Trading, LLC14,296$610.7K
PDT Partners, LLC14,847$601.0K
Bridgefront Capital, LLC10,736$434.6K
American Century Companies Inc10,046$406.7K
HSBC Holdings PLC8,647$343.3K
Jefferies Financial Group Inc.8,000$323.8K
Oppenheimer & Co Inc7,330$296.7K
Edgestream Partners, L.P.6,947$281.2K
Nomura Holdings Inc6,562$265.6K
SIH Partners, LLLP5,018$203.1K
Quadrant Capital Group LLC573$23.2K
Point72 Hong Kong Ltd571$23.1K
Reyes Financial Architecture, Inc.450$18.2K
Coldstream Capital Management Inc253$10.2K
Rise Advisors, LLC22$891
Stephens Consulting, LLC20$810
Boston Private Wealth LLC8$324

Not filed for Q2 2025 yet (1)

Institutions that held Akero Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AKRO in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Lindbrook Capital, LLC1,609$65.1K